Where does Benvenue Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Benvenue Medical, Inc. ranks #11,936 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Benvenue Medical, Inc. hold?

Benvenue Medical, Inc. holds 25 US utility patents granted between 2015 and 2020, spanning 3 technology areas.

What is Benvenue Medical, Inc.'s Innovation Score?

Benvenue Medical, Inc. has an Innovation Score of 30.2 out of 100 (34th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Benvenue Medical, Inc. focus on?

Benvenue Medical, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 24 patents, ranking #754 of 7,127 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Benvenue Medical, Inc.'s patent grant rate increasing or decreasing?

Benvenue Medical, Inc.'s recent grant velocity is -86% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Benvenue Medical, Inc.'s patents?

Benvenue Medical, Inc.'s patents average 21.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Benvenue Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Benvenue Medical, Inc.

USPTO PatentsView assignee record - 25 granted patents across 3 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Benvenue ranks #11,936 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 3 technology areas.

#11,936
of 49,997 US assignees by volume: 34th percentile
by Innovation Score (30.2/100): 21.4
avg claims per patent: -86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11936 · US Corporation #11,936 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #11,936/49,997
PHOTO-FINISH Baby Jogger
CPC-NARROW A61B · 3 areas
INNOV-THIN 30.2/100
CLAIMS-DENSE 21.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -86% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Baby Jogger, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Benvenue’s 30.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (37%) Velocity 0.0 pts (0%) Breadth 6.1 pts (20%) Claim depth 12.8 pts (42%)

Qualcomm Incorporated · highest

85
Benvenue Medical · this assignee

30
Enterin · near

30
Excelliance MOS · near

30
Aqua · near

30
Joingo · near

30
3D Lighting… · lowest

7

What this shows Benvenue's Innovation Score is 30.2/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Benvenue?

Each dot is one of Benvenue’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Benvenue’s own 21.4 claims/patent is ABOVE the 15.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Benvenue vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Benvenue's grants concentrate

Benvenue Medical, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 96% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (9 grants) versus a trough of 2 in 2018. By volume, Benvenue sits between Borgwarner Sweden AB and BioCardia Inc..

Borgwarner Sweden…

25
Brillnics Singapo…

25
Buffalo

25
Baby Jogger

25
Bespoke

25
Bicyclerd

25
Bio-pharm Solutio…

25
Biocardia

25
Benvenue Medical ◀

25

What this shows Benvenue holds 25 patents at rank #11,940, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Benvenue

By rank, the assignees closest to #11,940 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Benvenue's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Benvenue, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Benvenue ranks #754 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (30 here).

Excelliance MOS Corporation 30 Enterin, Inc. 30 Aqua Co., Ltd. 30 Joingo, LLC 30

Benvenue's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 34th percentile higher than 34% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Benvenue Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	36.0%
2016	4	16.0%
2017	3	12.0%
2018	2	8.0%
2019	4	16.0%
2020	3	12.0%

Which technologies does Benvenue Medical, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 24

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 20

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 6

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Benvenue Medical, Inc.'s patent record in context - here's where to go next.

Benvenue Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 96% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #11,936 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Benvenue Medical, Inc. against Borgwarner Sweden AB, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.